Illness	Number of cases
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8)	188
Malignant neoplasm of prostate (C61)	134
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	126
Hyperplasia of prostate (N40)	115
Calculus of kidney and ureter - Calculus of kidney (N20.0)	91
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21)	87
Unspecified haematuria (R31)	73
Calculus of kidney and ureter - Calculus of ureter (N20.1)	68
Obstructive and reflux uropathy (N13.3)	48
Malignant neoplasm of bladder - Malignant neoplasm of lateral wall of bladder (C67.2)	46

Top 10 treatments

Treatment	Number
Examination of the urethra and the urinary bladder by endoscopy (1-661)	740
Injection or administration of medicines into the urinary bladder (8-132.3)	547
X-rays of the kidney and urinary tract with contrast medium (3-13d.5)	419
Insertion of a small tube (cannula) or catheter in the kidney or urinary tract for the drainage of fluid other than urine (8-147.x)	344
Insertion, exchange or removal of a ureteral stent (8-137.00)	254
Computed tomography (CT) of the abdomen without contrast medium (3-207)	238
Insertion, exchange or removal of a ureteral stent (8-137.10)	226
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40)	192
(9-984.7)	170
(9-984.b)	164

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2200

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

External quality assurance according to the DMP

Diabetes mellitus Typ 1

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ01

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
79	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
60	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
60	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Participation in multi-centre phase III/IV studies
Doctoral supervision
Student training (clinical traineeship / internship year)
Lectureships / teaching posts at colleges and universities
Project-related cooperation with colleges and universities